Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.
Autori:
Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G.
Fonte:
Int J Cancer 2013; 133: 2004-9. doi: 10.1002/ijc.28186.